The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

•Prevalence of NAFLD in patients with type 2 diabetes mellitus is more than 2-fold higher than in the general population. •The overall prevalence of NAFLD among patients with type 2 diabetes mellitus is 55.5%. •The global prevalence of non-alcoholic steatohepatitis among patients with type 2 diabetes is 37.3%. •Of the patients with NAFLD and type 2 diabetes mellitus who undergo liver biopsy, 17% have advanced fibrosis. Background & Aims Although...